YahooOctober 26, 2026 at 7:00 PM NY20 Hours Ago
Bank of America backs Pharvaris on breakthrough for rare swelling disease
BofA sees the recent dip in PHVS’s share price as a buying chance ahead of two big FDA decisions in 2027.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
